The major reason why the said letter has gained much attention from different quarters is that it was from the office of Dr. Terrence L. Boos who is the Section Chief of the Drug and Chemical Evaluation Section. The section is under the Office of Diversion Control in the DEA and this particular letter was written to the Executive Secretary of the Board of Pharmacy of Alabama who requested a control status update on delta-8 THC. This means the contents of the letter can easily be used to juxtapose the current stand of the DEA as it applies to substance control for delta-8 THC.
Legal on paper, restricted in practice. Inside Germany’s cannabis system, where cultivation is allowed but…
The idea may sound strange: a tobacco plant producing compounds like psilocybin or DMT. Sounds…
The term “addiction” gets thrown around quite freely in everyday language—this is nothing new. Who…
Three days before the Trump administration moved medical marijuana to Schedule III, a new YouGov…
On April 23, 2026, the Trump administration officially moved FDA-approved marijuana products and marijuana products…
Here we are in 2026, and a conflict that was supposed to wrap up in…